Next Article in Journal
CD34+ Cell Dose, Measurable Residual Disease, and Outcome After Myeloablative HLA-Matched Peripheral Blood Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia
Previous Article in Journal
Efficacy and Safety of Chemotherapy Combined with Hormonal Therapy in Heavily Pretreated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ELSA/KGOG3049): A Multicenter Pilot Study
 
 
Article

Article Versions Notes

Cancers 2025, 17(14), 2321; https://doi.org/10.3390/cancers17142321
Action Date Notes Link
article xml file uploaded 12 July 2025 09:52 CEST Original file -
article xml uploaded. 12 July 2025 09:52 CEST Update -
article pdf uploaded. 12 July 2025 09:52 CEST Version of Record https://www.mdpi.com/2072-6694/17/14/2321/pdf-vor
article html file updated 12 July 2025 09:54 CEST Original file -
article xml file uploaded 15 July 2025 03:35 CEST Update -
article xml uploaded. 15 July 2025 03:35 CEST Update -
article pdf uploaded. 15 July 2025 03:35 CEST Updated version of record https://www.mdpi.com/2072-6694/17/14/2321/pdf-vor
article html file updated 15 July 2025 03:36 CEST Update -
article xml file uploaded 18 July 2025 07:57 CEST Update -
article xml uploaded. 18 July 2025 07:57 CEST Update https://www.mdpi.com/2072-6694/17/14/2321/xml
article pdf uploaded. 18 July 2025 07:58 CEST Updated version of record https://www.mdpi.com/2072-6694/17/14/2321/pdf
article html file updated 18 July 2025 08:00 CEST Update https://www.mdpi.com/2072-6694/17/14/2321/html
Back to TopTop